Arnuity Ellipta Drug Use Investigation

Trial Profile

Arnuity Ellipta Drug Use Investigation

Phase of Trial: Phase IV

Latest Information Update: 31 Oct 2017

At a glance

  • Drugs Fluticasone furoate (Primary)
  • Indications Asthma
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 26 Oct 2017 Status changed from not yet recruiting to recruiting.
    • 06 Jul 2017 Planned initiation date changed from 1 Jul 2017 to 31 Aug 2017.
    • 15 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top